Participants 93 136 4
pertussis vaccine efficacy trial in Germany
Participants 261 282 5
DT vaccine recipients
Participants 335 649 3
sample of subjects in each vaccine group at approximately 3-month intervals from which antibody kinetic curves were constructed, which allowed us to estimate specific antibody values to pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin and fimbriae-2 at the time of exposure in the household setting
